IntrinsicIntrinsic
← Scroll for more →

Financial Statements — REPL

Balance Sheet

(in billions USD)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Cash & Equivalents0.310.190.210.120.100.100.110.170.110.150.070.100.080.110.150.210.090.110.110.13
Short-term Investments0.000.010.060.150.220.310.370.360.320.320.350.370.420.430.440.410.280.280.290.29
Inventory0.01--------------------------------------
Total Current Assets0.320.200.280.280.330.410.500.550.440.480.430.480.510.550.590.620.380.400.400.43
Property, Plant & Equipment0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.01
Total Non-current Assets*0.010.010.010.010.010.010.010.010.010.010.050.010.010.010.050.010.010.010.060.01
Total Assets0.370.250.330.330.390.470.550.600.500.530.490.530.560.600.650.680.440.460.460.49
Accounts Payable0.010.000.010.010.010.020.010.010.010.000.000.000.000.000.010.000.000.000.000.00
Total Current Liabilities0.050.040.060.050.050.060.060.050.040.040.040.040.040.030.030.030.020.020.020.02
Long-term Debt0.100.080.080.050.050.050.050.050.050.050.040.040.030.030.030.03--------
Total Non-current Liabilities*0.120.110.110.070.070.070.070.070.070.070.070.070.060.060.060.060.030.030.030.03
Total Liabilities0.170.150.170.120.130.130.140.120.120.110.110.110.100.090.090.080.050.050.050.05
Retained Earnings(1.39)(1.33)(1.26)(1.19)(1.12)(1.04)(0.95)(0.87)(0.81)(0.76)(0.70)(0.65)(0.60)(0.54)(0.49)(0.44)(0.40)(0.35)(0.31)(0.28)
Total Stockholder Equity0.200.110.170.210.260.340.420.480.380.430.370.420.470.510.560.600.380.410.410.44
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Research & Development34.3749.2852.3253.1457.8857.8455.0248.0043.4542.9742.5842.8549.1040.4437.9530.2628.8329.4821.7419.35
Selling, General & Admin21.9218.97--18.7326.4132.5824.3018.0215.4714.4016.1813.6914.7315.2115.0411.3712.7511.4010.2510.35
Total Operating Expenses56.2868.2573.3471.8784.2990.4279.3366.0258.9257.3758.7556.5463.8355.6553.0041.6341.5840.8831.9929.70
Operating Income(56.28)(68.25)(73.34)(71.87)(84.29)(90.42)(79.32)(66.02)(58.92)(57.37)(58.75)(56.54)(63.83)(55.65)(52.99)(41.63)(41.58)(40.88)(31.99)(29.70)
Pretax Income----(73.46)(71.24)----(74.24)(65.76)(53.05)(53.77)(55.14)(50.65)(60.24)(49.35)(48.95)----------
Tax Provision----(0.24)(0.31)0.000.00(0.11)0.570.000.00(0.06)0.47(0.20)0.200.29----------
Net Income(57.12)(69.77)(73.22)(70.93)(83.10)(86.69)(74.13)(66.34)(53.05)(53.77)(55.07)(51.12)(60.04)(49.55)(49.24)(39.69)(43.10)(42.25)(31.70)(29.67)
Basic EPS(0.54)(0.72)(0.76)(0.77)(0.90)(0.95)(0.82)(0.79)(0.68)(0.78)(0.82)(0.77)(0.90)(0.75)(0.73)(0.69)(0.79)(0.78)(0.60)(0.57)
Diluted EPS(0.54)(0.72)(0.76)(0.77)(0.90)(0.95)(0.82)(0.79)(0.68)(0.78)(0.82)(0.77)(0.90)(0.75)(0.73)(0.69)(0.79)(0.78)(0.60)(0.57)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Operating Cash Flow(47.70)(75.73)(56.16)(65.95)(81.21)(77.02)(53.73)(50.71)(38.64)(49.17)(46.17)(47.12)(43.59)(48.59)(32.80)(28.59)(33.21)(33.45)(22.56)(18.35)
Capital Expenditures0.080.010.010.141.342.741.131.802.081.671.741.722.200.450.250.560.401.071.150.47
Free Cash Flow*(47.78)(75.73)(56.17)(66.09)(82.55)(79.76)(54.86)(52.51)(40.72)(50.84)(47.91)(48.84)(45.79)(49.04)(33.05)(29.14)(33.61)(34.52)(23.71)(18.81)
Investing Cash Flow9.7649.9986.5175.1284.1765.05(7.70)(46.32)0.4629.7723.2053.9612.687.36(22.75)(125.10)0.045.32(4.33)(13.42)
Financing Cash Flow160.550.8055.6810.450.32(0.16)(0.13)155.93(0.04)96.64(0.13)14.870.441.11(0.08)271.447.4232.520.363.97
← Scroll for more columns →

* Derived from reported values